Antibody drug conjugate trang 1 tải miễn phí từ tailieuXANH

"Antibody drug conjugate" trang 1 - tải miễn phí từ tailieuXANH

Determination of cellular processing rates for a Trastuzumab-Maytansinoid antibody-drug conjugate (ADC) highlights key parameters for ADC design

12 72 0

ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition

11 170 1

Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation

12 70 0

Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for Pcadherin targeted therapy: A retrospective cohort study

9 42 1

Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): Protocol of an open-label, singlearm phase II trial

7 222 1

Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II)

11 45 0

$Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol$

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol

8 75 0